HARVARD BIOSCIENCE INC — Director's Dealing 2020

Jun 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-06-11

Reporting Person: LOY BERTRAND (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-11	Common Stock	D	1767	$0.00	Disposed	221726	Direct
2020-06-18	Common Stock	A	28100	$0.00	Acquired	249826	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	68466	Indirect

Footnotes

F1: On January 2, 2020, the Reporting Person received a retainer award of 30,000 restricted stock units of the Issuer, vesting in four equal installments on March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020. 3,200 of the restricted stock units were granted in connection with the Reporting Person's membership on the Issuer's Audit Committee. On June 11, 2020, the Reporting Person was appointed to serve on the Issuer's Compensation Committee and stepped down from serving on the Audit Committee. In accordance with the Issuer's non-employee director compensation policy, the Reporting Person forfeited 1,767 restricted stock units as a result of the committee change.

F2: Includes (a) a restricted stock unit award with 20,100 remaining unvested shares vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020, and (b) 201,626 shares of common stock held by the Reporting Person.

F3: Represents an award of 28,100 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 11, 2020, immediately prior to the commencement of such meeting, and (ii) June 18, 2021.

F4: Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above.